Gangliang Zhong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gangliang Zhong has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Jiang Du
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
5 shared publications - Min Zhao
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4 shared publications Yicheng Wei
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publicationsJingyang Liu
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsTianzhen Chen
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsXiyuan Zhang
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications
Latest Publications
- Open Access
- 2 April 2026
- Published by Akademiai Kiado Zrt. in Journal of Behavioral Addictions
- Vol. 15 (1) , 371-383
Diminishing loss sensitivity during risky decision-making among male individuals with gambling disorder
Background and aims: Gambling disorder (GD) poses severe impacts on both individuals and society. Impairment in risky decision-making is a key behavioral characteristic of GD, but the underlying cognitive processes of these deficits remain unclear. Methods: A total of 100 male participants with GD and 59 healthy controls were recruited to complete psychological assessments and the Balloon Analog Risk Task. Since GD involved abnormal loss evaluation, we developed a novel cognitive model incorporating diminishing loss sensitivity and revealed the processes underlying the risk-taking behaviors with hierarchical Bayesian analysis. Results: Participants with GD exhibited stronger loss aversion ( H 1 = 50.00, p < 0.001, η 2 = 0.325) but faster-diminishing loss sensitivity ( H 1 = 24.60, p < 0.001, η 2 = 0.152), regardless of severity. The faster-diminishing loss sensitivity can explain the deficits in the overall performance of risky decision-making ( H 1 = 6.79, p = 0.009, η 2 = 0.039; = 206.81, 95% HDI [135.13, 278.49], t 93 = 5.66, p < 0.001, Cohen's d = 0.565). Overconfident prior belief ( H 1 = 8.58, p = 0.003, η 2 = 0.050) and higher updating rate ( H 1 = 7.91, p = 0.005, η 2 = 0.049) were observed among participants with GD. Slower diminishing loss sensitivity was negatively correlated with higher non-planning impulsiveness ( R = −0.24, p = 0.015). Discussion and Conclusions: This research provides novel perspectives on cognitive processes underlying the risky decision-making of GD, highlighting the role of diminishing loss sensitivity during loss evaluation and its clinical implications, which inspire future research on assessment and therapy for GD.
- 2 April 2026
- Published by Akademiai Kiado Zrt. in Journal of Behavioral Addictions
- Vol. 15 (1) , 371-383
Open AccessDiminishing loss sensitivity during risky decision-making among male individuals with gambling disorder
Background and aims: Gambling disorder (GD) poses severe impacts on both individuals and society. Impairment in risky decision-making is a key behavioral characteristic of GD, but the underlying cognitive processes of these deficits remain unclear. Methods: A total of 100 male participants with GD and 59 healthy controls were recruited to complete psychological assessments and the Balloon Analog Risk Task. Since GD involved abnormal loss evaluation, we developed a novel cognitive model incorporating diminishing loss sensitivity and revealed the processes underlying the risk-taking behaviors with hierarchical Bayesian analysis. Results: Participants with GD exhibited stronger loss aversion ( H 1 = 50.00, p < 0.001, η 2 = 0.325) but faster-diminishing loss sensitivity ( H 1 = 24.60, p < 0.001, η 2 = 0.152), regardless of severity. The faster-diminishing loss sensitivity can explain the deficits in the overall performance of risky decision-making ( H 1 = 6.79, p = 0.009, η 2 = 0.039; = 206.81, 95% HDI [135.13, 278.49], t 93 = 5.66, p < 0.001, Cohen's d = 0.565). Overconfident prior belief ( H 1 = 8.58, p = 0.003, η 2 = 0.050) and higher updating rate ( H 1 = 7.91, p = 0.005, η 2 = 0.049) were observed among participants with GD. Slower diminishing loss sensitivity was negatively correlated with higher non-planning impulsiveness ( R = −0.24, p = 0.015). Discussion and Conclusions: This research provides novel perspectives on cognitive processes underlying the risky decision-making of GD, highlighting the role of diminishing loss sensitivity during loss evaluation and its clinical implications, which inspire future research on assessment and therapy for GD.
- Open Access
- 23 June 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 1-11
Transdiagnostic neuromodulation of impulsivity: current status and future trajectories
Impulsivity, increasingly perceived as a transdiagnostic characteristic, significantly influences diverse psychiatric conditions and emanates beyond the boundaries defined by traditional classification systems. Transdiagnostic research has shed light on the complex clinical manifestations of impulsivity, and the underpinning neural circuitry. The pressing challenge now is to translate this enhanced understanding into precise and potent interventions tailored to these different aspects of impulsivity. Recent advancements in neuromodulation, specifically targeting brain circuits, have provided encouraging evidence for improvements in clinical symptoms, and neural circuitry across various psychiatric conditions, signposting a transformative phase in crafting interventions that tackle impulsivity from a transdiagnostic perspective. However, the field continues to ascertain a universally embraced framework that effectively amalgamates these discoveries into a unified clinical methodology. The Research Domain Criteria (RDoC) delivers a neuroscientifically informed framework that aims to reconcile the neurobiological underpinnings with clinical symptoms, thereby facilitating targeted neuromodulation strategies. In this context, we propose a pioneering RDoC-compliant framework that strategically targets the neural circuits implicated in clinical impulsivity symptoms, applicable across diagnostic categories. Furthermore, we introduce a set of meticulously selected tools for each stage within this framework, thus reinforcing its applicability and aiding future investigative pursuits in this area.
- 23 June 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 1-11
Open AccessTransdiagnostic neuromodulation of impulsivity: current status and future trajectories
Impulsivity, increasingly perceived as a transdiagnostic characteristic, significantly influences diverse psychiatric conditions and emanates beyond the boundaries defined by traditional classification systems. Transdiagnostic research has shed light on the complex clinical manifestations of impulsivity, and the underpinning neural circuitry. The pressing challenge now is to translate this enhanced understanding into precise and potent interventions tailored to these different aspects of impulsivity. Recent advancements in neuromodulation, specifically targeting brain circuits, have provided encouraging evidence for improvements in clinical symptoms, and neural circuitry across various psychiatric conditions, signposting a transformative phase in crafting interventions that tackle impulsivity from a transdiagnostic perspective. However, the field continues to ascertain a universally embraced framework that effectively amalgamates these discoveries into a unified clinical methodology. The Research Domain Criteria (RDoC) delivers a neuroscientifically informed framework that aims to reconcile the neurobiological underpinnings with clinical symptoms, thereby facilitating targeted neuromodulation strategies. In this context, we propose a pioneering RDoC-compliant framework that strategically targets the neural circuits implicated in clinical impulsivity symptoms, applicable across diagnostic categories. Furthermore, we introduce a set of meticulously selected tools for each stage within this framework, thus reinforcing its applicability and aiding future investigative pursuits in this area.
- Open Access
- 24 May 2025
- Published by Springer Nature in Globalization and Health
- Vol. 21 (1) , 1-13
Trends and cross-country inequalities of alcohol use disorders: findings from the global burden of disease study 2021
Alcohol use disorder (AUD) imposes a significant burden on individuals and society. With globalization, transnational alcohol corporations influence policy enforcement and consumer behavior, hindering cost-effective and evidence-based interventions such as reducing alcohol availability and restricting alcohol advertising, as recommended in the World Health Organization (WHO) Best Buys for the prevention and control of noncommunicable diseases (NCDs).This study utilizes the Global Burden of Disease Study 2021 dataset to examine global and regional disparities, offering key insights into the global trends of AUD and addressing critical research gaps. The global age-standardised prevalence of alcohol use disorders among individuals aged 15 years and older decreased from 1,698 per 100,000 in 1990 to 1,335 per 100,000 in 2021, with an average annual percent change of -0.78%. Similarly, the average annual percent change for mortality and disability-adjusted life years were − 0.82% and − 0.83%, respectively. Importantly, the age-standardised decline in alcohol use disorders was more pronounced in females compared to males (prevalence: -0.82% versus − 0.75%; mortality: -1.22% versus − 0.73%; disability-adjusted life years: -0.95% versus − 0.79%). The age-standardised prevalence of alcohol use disorders may remain higher among males until the year 2040. For the older adult groups aged 55 to 74, there was no statistically significant decline in alcohol use disorders mortality rates (Ps ≥ 0.17). Furthermore, countries characterized by a high sociodemographic index did not exhibit a significant reduction in mortality (average annual percent change: 0.02%). Between 1990 and 2021, high levels of alcohol consumption and experiences of childhood sexual abuse were identified as major risk factors for alcohol use disorders. Understanding the trends of AUD in the context of globalization is crucial. Given that certain populations continue to experience persistent alcohol-related issues, protecting these groups from the influence of transnational alcohol corporations through effective policy measures such as strengthening regulations on alcohol advertising targeting older adults, and establishing independent regulatory agencies may be a key strategy for reducing the global health burden of AUD.
- 24 May 2025
- Published by Springer Nature in Globalization and Health
- Vol. 21 (1) , 1-13
Open AccessTrends and cross-country inequalities of alcohol use disorders: findings from the global burden of disease study 2021
Alcohol use disorder (AUD) imposes a significant burden on individuals and society. With globalization, transnational alcohol corporations influence policy enforcement and consumer behavior, hindering cost-effective and evidence-based interventions such as reducing alcohol availability and restricting alcohol advertising, as recommended in the World Health Organization (WHO) Best Buys for the prevention and control of noncommunicable diseases (NCDs).This study utilizes the Global Burden of Disease Study 2021 dataset to examine global and regional disparities, offering key insights into the global trends of AUD and addressing critical research gaps. The global age-standardised prevalence of alcohol use disorders among individuals aged 15 years and older decreased from 1,698 per 100,000 in 1990 to 1,335 per 100,000 in 2021, with an average annual percent change of -0.78%. Similarly, the average annual percent change for mortality and disability-adjusted life years were − 0.82% and − 0.83%, respectively. Importantly, the age-standardised decline in alcohol use disorders was more pronounced in females compared to males (prevalence: -0.82% versus − 0.75%; mortality: -1.22% versus − 0.73%; disability-adjusted life years: -0.95% versus − 0.79%). The age-standardised prevalence of alcohol use disorders may remain higher among males until the year 2040. For the older adult groups aged 55 to 74, there was no statistically significant decline in alcohol use disorders mortality rates (Ps ≥ 0.17). Furthermore, countries characterized by a high sociodemographic index did not exhibit a significant reduction in mortality (average annual percent change: 0.02%). Between 1990 and 2021, high levels of alcohol consumption and experiences of childhood sexual abuse were identified as major risk factors for alcohol use disorders. Understanding the trends of AUD in the context of globalization is crucial. Given that certain populations continue to experience persistent alcohol-related issues, protecting these groups from the influence of transnational alcohol corporations through effective policy measures such as strengthening regulations on alcohol advertising targeting older adults, and establishing independent regulatory agencies may be a key strategy for reducing the global health burden of AUD.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Asian Journal of Social Health and Behavior
- Vol. 8 (1) , 9-14
Chinese South Oaks Gambling Screen: A Study on Reliability and Validity in Mainland China
Introduction: This study aims to translate the South Oaks Gambling Screen (SOGS) into Chinese and to verify the reliability and validity of the scale in the mainland Chinese population. Methods: This study collected 283 participants from October 2023 to April 2024, including a general population group ( n = 159) and a gambling disorder group ( n = 124). We translated the Chinese SOGS (C-SOGS) in a standard localization process and examined the internal consistency, test–retest reliability, and content validity of the C-SOGS, and to refine the structure of the scale, we did an exploratory factor analysis of all the C-SOGS items. We also use cross-tabulation analyses and receiver operating characteristic curve to examine the structural validity of this scale. Results: The scale demonstrated high internal consistency (α = 0.97) and test–retest reliability (0.80). Exploratory factor analysis resulted in a two-dimensional solution accounting for 70.98% of the total variance: a first factor composed mainly of questions related to the problems and consequences caused by gambling and a second-factor encompassing questions about the sources of gambling funds. Its content validity was over 0.80 and 0.90 in Item-Content Validity Index and Scale-Content Validity Index, respectively. The C-SOGS demonstrated excellent classification accuracy with a false-positive rate of 0.10 when screening the gambling population among all participants. The Discriminant Power Coefficient (D prime) of the C-SOGS was 2.92. Conclusion: We localized SOGS to obtain C-SOGS. C-SOGS has two dimensions and demonstrates high reliability, validity, and classification accuracy.
- 1 January 2025
- Published by Wolters Kluwer Health in Asian Journal of Social Health and Behavior
- Vol. 8 (1) , 9-14
Open AccessChinese South Oaks Gambling Screen: A Study on Reliability and Validity in Mainland China
Introduction: This study aims to translate the South Oaks Gambling Screen (SOGS) into Chinese and to verify the reliability and validity of the scale in the mainland Chinese population. Methods: This study collected 283 participants from October 2023 to April 2024, including a general population group ( n = 159) and a gambling disorder group ( n = 124). We translated the Chinese SOGS (C-SOGS) in a standard localization process and examined the internal consistency, test–retest reliability, and content validity of the C-SOGS, and to refine the structure of the scale, we did an exploratory factor analysis of all the C-SOGS items. We also use cross-tabulation analyses and receiver operating characteristic curve to examine the structural validity of this scale. Results: The scale demonstrated high internal consistency (α = 0.97) and test–retest reliability (0.80). Exploratory factor analysis resulted in a two-dimensional solution accounting for 70.98% of the total variance: a first factor composed mainly of questions related to the problems and consequences caused by gambling and a second-factor encompassing questions about the sources of gambling funds. Its content validity was over 0.80 and 0.90 in Item-Content Validity Index and Scale-Content Validity Index, respectively. The C-SOGS demonstrated excellent classification accuracy with a false-positive rate of 0.10 when screening the gambling population among all participants. The Discriminant Power Coefficient (D prime) of the C-SOGS was 2.92. Conclusion: We localized SOGS to obtain C-SOGS. C-SOGS has two dimensions and demonstrates high reliability, validity, and classification accuracy.
- Open Access
- 12 April 2024
- Published by Wiley in General Psychiatry
- Vol. 37 (2) , e101477
Understanding and addressing the challenges of online gambling addiction in mainland China
- 12 April 2024
- Published by Wiley in General Psychiatry
- Vol. 37 (2) , e101477
Open AccessUnderstanding and addressing the challenges of online gambling addiction in mainland China